MedTrace Logo

Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate Asthma

NCT00830505 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2019-05-08

No results posted yet for this study

Summary

The purpose of this study is to compare the effects of Fluticasone/ salmeterol combination and double the dose of fluticasone on airway hyper-responsiveness to methacholine in a randomised, double blind, double dummy, cross-over trial.

Conditions

Interventions

DRUG

fluticasone/salmeterol

2 puffs twice a day for 2 weeks

DRUG

fluticasone

2 puffs twice a day for 2 weeks

Sponsors & Collaborators

  • University of Dundee

    lead OTHER

Principal Investigators

  • Karine L Clearie, MBBS, MRCP · Asthma and Allergy Research Group

  • Brian J Lipworth, MBchB · Asthma and Allergy Research Group

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00830505 on ClinicalTrials.gov